跳至主要内容
临床试验/CTRI/2023/04/051669
CTRI/2023/04/051669已完成Unknown

The cardiovascular, renal and metabolic effects of add-on therapy with dapagliflozin in patients with uncontrolled type 2 diabetes: an observational analytical study from a rural secondary hospital in South India.

THE SCHIEFFELIN INSTITUTE OF HEALTH-RESEARCH AND LEPROSY CENTER0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
已完成
发起方